The clinical meaning of pre- and post-ablation thyroglobulin levels at first radioiodine therapy in patients with papillary thyroid cancer

Background/Aims This study was conducted to identify prognostic factors in patients with papillary thyroid cancer (PTC) at the time of first radioactive iodine (RAI) therapy, and to evaluate the clinical value of the thyroglobulin (Tg) increase after RAI. Methods Serum Tg was sampled prior to (pre-T...

Full description

Bibliographic Details
Main Authors: Hee Kyung Kim, Jee Hee Yoon, Jin Seong Cho, Seong Young Kwon, Su Woong Yoo, Ho-Cheol Kang
Format: Article
Language:English
Published: The Korean Association of Internal Medicine 2020-09-01
Series:The Korean Journal of Internal Medicine
Subjects:
Online Access:http://www.kjim.org/upload/pdf/kjim-2018-173.pdf
id doaj-5768292293164cfc9eadd250b1fd1316
record_format Article
spelling doaj-5768292293164cfc9eadd250b1fd13162021-08-10T06:00:15ZengThe Korean Association of Internal MedicineThe Korean Journal of Internal Medicine1226-33032005-66482020-09-013551164117210.3904/kjim.2018.173170219The clinical meaning of pre- and post-ablation thyroglobulin levels at first radioiodine therapy in patients with papillary thyroid cancerHee Kyung Kim0Jee Hee Yoon1Jin Seong Cho2Seong Young Kwon3Su Woong Yoo4Ho-Cheol Kang5 Departments of Internal Medicine, Chonnam National University Medical School, Gwangju, Korea Departments of Internal Medicine, Chonnam National University Medical School, Gwangju, Korea Departments of Surgery, Chonnam National University Medical School, Gwangju, Korea Departments of Nuclear Medicine, Chonnam National University Medical School, Gwangju, Korea Departments of Nuclear Medicine, Chonnam National University Medical School, Gwangju, Korea Departments of Internal Medicine, Chonnam National University Medical School, Gwangju, KoreaBackground/Aims This study was conducted to identify prognostic factors in patients with papillary thyroid cancer (PTC) at the time of first radioactive iodine (RAI) therapy, and to evaluate the clinical value of the thyroglobulin (Tg) increase after RAI. Methods Serum Tg was sampled prior to (pre-Tg) and 7 days after RAI (post-Tg) in 680 patients with PTC. Patients were classified into excellent response (ER), biochemical incomplete response (BCIR), structural incomplete response (SIR), and indeterminate response (IR) groups using dynamic risk stratification at 6 to 18 months after RAI therapy. Results After RAI therapy, 514 patients (75.6%) had an ER, 34 (5.0%) had a BCIR, 13 (2.0%) had an SIR, and 119 (17.5%) had an IR. Pre-Tg level was significantly different among the groups, with the highest level being in the SIR group, followed by the BCIR, IR, and ER groups. However, post-Tg levels were not different among the groups. Post-Tg level increased significantly after RAI therapy compared to the pre-Tg level (mean 13.8 ± 32.2 ng/mL vs. 2.5 ± 8.9 ng/mL). In 422 patients whose pre-Tg level was < 1 ng/mL, 205 had post-Tg levels < 1 ng/mL, while 167 had post-Tg levels of 1 to 10 ng/mL, and 50 had levels > 10 ng/mL. No difference was observed in the response to therapy. Differences in RAI dose and uptake pattern were observed among the three groups. Conclusions Pre-Tg was useful as a prognostic factor in patients with PTC. In patients with low pre-Tg, increased post-Tg may reflect remnant tissue and does not help predict the prognosis.http://www.kjim.org/upload/pdf/kjim-2018-173.pdfthyroid cancer, papillaryradioactive iodine therapythyroglobulinprognosistherapeutic response
collection DOAJ
language English
format Article
sources DOAJ
author Hee Kyung Kim
Jee Hee Yoon
Jin Seong Cho
Seong Young Kwon
Su Woong Yoo
Ho-Cheol Kang
spellingShingle Hee Kyung Kim
Jee Hee Yoon
Jin Seong Cho
Seong Young Kwon
Su Woong Yoo
Ho-Cheol Kang
The clinical meaning of pre- and post-ablation thyroglobulin levels at first radioiodine therapy in patients with papillary thyroid cancer
The Korean Journal of Internal Medicine
thyroid cancer, papillary
radioactive iodine therapy
thyroglobulin
prognosis
therapeutic response
author_facet Hee Kyung Kim
Jee Hee Yoon
Jin Seong Cho
Seong Young Kwon
Su Woong Yoo
Ho-Cheol Kang
author_sort Hee Kyung Kim
title The clinical meaning of pre- and post-ablation thyroglobulin levels at first radioiodine therapy in patients with papillary thyroid cancer
title_short The clinical meaning of pre- and post-ablation thyroglobulin levels at first radioiodine therapy in patients with papillary thyroid cancer
title_full The clinical meaning of pre- and post-ablation thyroglobulin levels at first radioiodine therapy in patients with papillary thyroid cancer
title_fullStr The clinical meaning of pre- and post-ablation thyroglobulin levels at first radioiodine therapy in patients with papillary thyroid cancer
title_full_unstemmed The clinical meaning of pre- and post-ablation thyroglobulin levels at first radioiodine therapy in patients with papillary thyroid cancer
title_sort clinical meaning of pre- and post-ablation thyroglobulin levels at first radioiodine therapy in patients with papillary thyroid cancer
publisher The Korean Association of Internal Medicine
series The Korean Journal of Internal Medicine
issn 1226-3303
2005-6648
publishDate 2020-09-01
description Background/Aims This study was conducted to identify prognostic factors in patients with papillary thyroid cancer (PTC) at the time of first radioactive iodine (RAI) therapy, and to evaluate the clinical value of the thyroglobulin (Tg) increase after RAI. Methods Serum Tg was sampled prior to (pre-Tg) and 7 days after RAI (post-Tg) in 680 patients with PTC. Patients were classified into excellent response (ER), biochemical incomplete response (BCIR), structural incomplete response (SIR), and indeterminate response (IR) groups using dynamic risk stratification at 6 to 18 months after RAI therapy. Results After RAI therapy, 514 patients (75.6%) had an ER, 34 (5.0%) had a BCIR, 13 (2.0%) had an SIR, and 119 (17.5%) had an IR. Pre-Tg level was significantly different among the groups, with the highest level being in the SIR group, followed by the BCIR, IR, and ER groups. However, post-Tg levels were not different among the groups. Post-Tg level increased significantly after RAI therapy compared to the pre-Tg level (mean 13.8 ± 32.2 ng/mL vs. 2.5 ± 8.9 ng/mL). In 422 patients whose pre-Tg level was < 1 ng/mL, 205 had post-Tg levels < 1 ng/mL, while 167 had post-Tg levels of 1 to 10 ng/mL, and 50 had levels > 10 ng/mL. No difference was observed in the response to therapy. Differences in RAI dose and uptake pattern were observed among the three groups. Conclusions Pre-Tg was useful as a prognostic factor in patients with PTC. In patients with low pre-Tg, increased post-Tg may reflect remnant tissue and does not help predict the prognosis.
topic thyroid cancer, papillary
radioactive iodine therapy
thyroglobulin
prognosis
therapeutic response
url http://www.kjim.org/upload/pdf/kjim-2018-173.pdf
work_keys_str_mv AT heekyungkim theclinicalmeaningofpreandpostablationthyroglobulinlevelsatfirstradioiodinetherapyinpatientswithpapillarythyroidcancer
AT jeeheeyoon theclinicalmeaningofpreandpostablationthyroglobulinlevelsatfirstradioiodinetherapyinpatientswithpapillarythyroidcancer
AT jinseongcho theclinicalmeaningofpreandpostablationthyroglobulinlevelsatfirstradioiodinetherapyinpatientswithpapillarythyroidcancer
AT seongyoungkwon theclinicalmeaningofpreandpostablationthyroglobulinlevelsatfirstradioiodinetherapyinpatientswithpapillarythyroidcancer
AT suwoongyoo theclinicalmeaningofpreandpostablationthyroglobulinlevelsatfirstradioiodinetherapyinpatientswithpapillarythyroidcancer
AT hocheolkang theclinicalmeaningofpreandpostablationthyroglobulinlevelsatfirstradioiodinetherapyinpatientswithpapillarythyroidcancer
AT heekyungkim clinicalmeaningofpreandpostablationthyroglobulinlevelsatfirstradioiodinetherapyinpatientswithpapillarythyroidcancer
AT jeeheeyoon clinicalmeaningofpreandpostablationthyroglobulinlevelsatfirstradioiodinetherapyinpatientswithpapillarythyroidcancer
AT jinseongcho clinicalmeaningofpreandpostablationthyroglobulinlevelsatfirstradioiodinetherapyinpatientswithpapillarythyroidcancer
AT seongyoungkwon clinicalmeaningofpreandpostablationthyroglobulinlevelsatfirstradioiodinetherapyinpatientswithpapillarythyroidcancer
AT suwoongyoo clinicalmeaningofpreandpostablationthyroglobulinlevelsatfirstradioiodinetherapyinpatientswithpapillarythyroidcancer
AT hocheolkang clinicalmeaningofpreandpostablationthyroglobulinlevelsatfirstradioiodinetherapyinpatientswithpapillarythyroidcancer
_version_ 1721212776064483328